Idera Pharmaceuticals, Inc.

IDRA · NASDAQ
Analyze with AI
3/31/2023
12/31/2022
9/30/2022
6/30/2022
Operating Activities
Net Income-$22-$11-$3-$5
Dep. & Amort.$0$0$0$0
Deferred Tax-$0$6-$6$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2-$6$6$1
Other Non-Cash$13-$3-$0$0
Operating Cash Flow-$10-$13-$3-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$5$0
Investing Cash Flow$0$0$5$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0-$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$2$0$0
Financing Cash Flow-$0-$2$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$10-$15$2-$4
Supplemental Information
Beg. Cash$12$27$24$28
End Cash$2$12$27$24
Free Cash Flow-$10-$13-$3-$4